ArticleACS applied bio materials2025
Molybdenum Diboride (MoB
Hamide Aydın, Burcu Üstün, Utkan Şahintürk, Nurdan Sena Değirmenci, Fikrettin Şahin, Sedef Kaptan Usul, Ayşe Aslan, Muslum Demir, Ümran Kurtan
Abstract read
In one paragraphArticle in ACS applied bio materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Burcu ÜstünDepartment of Chemical Engineering, İstanbul University-Cerrahpaşa, Istanbul 34500, Türkiye.
Utkan ŞahintürkDepartment of Mechanical and Metal TechnologiesVocational School of Technical ScienceZ, Istanbul University-Cerrahpaşa, Istanbul 34500, Türkiye.
Nurdan Sena DeğirmenciDepartment of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul 34755, Türkiye.
Fikrettin ŞahinDepartment of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul 34755, Türkiye.
Sedef Kaptan UsulBioengineering Department, Gebze Technical University, Kocaeli 41400, Türkiye.
Ayşe AslanBioengineering Department, Gebze Technical University, Kocaeli 41400, Türkiye.
Muslum DemirMaterials Institute, The Scientific and Technological Research Council of Türkiye (TUBITAK) - Marmara Research Center (MAM), Gebze 41470, Türkiye.
Ümran KurtanDepartment of Materials and Materials Processing Technologies Vocational School of Technical Sciences, Istanbul University-Cerrahpaşa, istanbul 34500, Türkiye.ORCID 0000-0002-1279-7729 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Herein, nanocrystalline MoB
Indexed as
Anti-Bacterial AgentsAntineoplastic AgentsBiocompatible MaterialsMolybdenumNanoparticlesCell SurvivalDose-Response Relationship, DrugDrug Screening Assays, AntitumorEscherichia coliHumansMaterials TestingMicrobial Sensitivity TestsParticle SizeSaltsStaphylococcus aureusSurface PropertiesAnti-Bacterial AgentsAntineoplastic AgentsBiocompatible MaterialsMolybdenumSaltsantibacterial activitycytotoxicity on cancermolten saltmolybdenum diboride (MoB2)
Identifiers
PMID40654237
PMCPMC12365880
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390